Scaffold degradation elevates the collagen content and dynamic compressive modulus in engineered articular cartilage

Area of Science:

• Tissue Engineering
• Biomaterials Science
• Regenerative Medicine

Background:

• Engineered cartilage often relies on scaffolds that can impede matrix deposition and mechanical maturation.
• Controlled scaffold degradation is a potential strategy to improve engineered tissue properties.

Purpose of the Study:

• To investigate the effects of controlled scaffold removal on the collagen content and mechanical properties of engineered cartilage.
• To determine if scaffold degradation enhances matrix accumulation and mechanical function over time.

Main Methods:

• Immature bovine chondrocytes were encapsulated in agarose and cultured to day 42.
• Agarase treatment was applied to constructs, followed by continued culture to day 91.
• Compressive Young's modulus, dynamic modulus, DNA, collagen, and GAG content were assessed.

Main Results:

• Agarase treatment did not harm the cartilage matrix in explants.
• Early agarase treatment transiently decreased GAG content and Young's modulus, which recovered over time.
• By day 91, agarase-treated constructs exhibited significantly higher DNA, collagen, and dynamic modulus compared to controls.

Conclusions:

• Controlled scaffold degradation via agarase treatment improved collagen content and dynamic mechanical properties of engineered cartilage.
• Potential mechanisms include enhanced nutrient transport and space for matrix formation.
• This approach shows promise for developing scaffold-free engineered tissues for clinical applications.